Claessens, Anouk K. M.
Ramaekers, Bram L. T.
Lobbezoo, Dorien J. A.
van Kampen, Roel J. W.
de Boer, Maaike
van de Wouw, Agnes J.
Dercksen, M. Wouter
Geurts, Sandra M. E.
Joore, Manuela A.
Tjan-Heijnen, Vivianne C. G. http://orcid.org/0000-0002-3935-7440
Funding for this research was provided by:
ZonMw (80-82500-98-8003)
Maastricht Universitair Medisch Centrum
F. Hoffmann-La Roche
Article History
Accepted: 5 August 2020
First Online: 20 August 2020
Compliance with ethical standards
:
: A.K.M. Claessens: nothing to declare. B.L.T. Ramaekers: nothing to declare. D.J.A. Lobbezoo: Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); Novartis BV; Roche; Pfizer. R.J.W. van Kampen: Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003). M. de Boer: Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); Novartis BV; Roche; Pfizer; Eisai; Eli Lilly. A.J. van de Wouw: nothing to declare. M.W. Dercksen: nothing to declare. S.M.E. Geurts: Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); Novartis BV; Roche; Pfizer; Eli Lilly. M.A. Joore: nothing to declare. V.C.G. Tjan-Heijnen: Netherlands Organization for Health Research and Development (ZonMw: 80-82500-98-8003); Novartis BV; Roche; Pfizer; Eisai; E. Lilly.
: The study reported here was approved by the Medical Research Ethics Committee of Maastricht University Medical Center as part of the SONABRE Registry.
: Informed consent was obtained from all patients prior to inclusion.